| Dr Peter Edward Carra, OD | |
|
Unit 2060 Box 51st, Apo, AP 96278-2060 | |
| (314) 784-0196 | |
| Not Available |
| Full Name | Dr Peter Edward Carra |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | Unit 2060 Box 51st, Apo, Armed Forces Pacific |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417148255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 009756 (New York) | Secondary |
| 152W00000X | Optometrist | 0618001684 (Virginia) | Secondary |
| 152W00000X | Optometrist | OPC4303 (Florida) | Primary |
| Provider Name | Northern Virginia Eye Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1336204585 PECOS PAC ID: 0648203026 Enrollment ID: O20050915000849 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Provider Name | Stafford Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063578524 PECOS PAC ID: 7810083698 Enrollment ID: O20071010000506 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Provider Name | Winchester Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649417387 PECOS PAC ID: 6901045384 Enrollment ID: O20130614000354 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Provider Name | Front Royal Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881031615 PECOS PAC ID: 2769625755 Enrollment ID: O20130823000092 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Provider Name | South Hill Optometry Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093763203 PECOS PAC ID: 0941431233 Enrollment ID: O20140331000906 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Provider Name | Myeyedr Optometry Of Virginia, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174933691 PECOS PAC ID: 0143448456 Enrollment ID: O20140828001354 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Edward Carra, OD Unit 2060 Box 51st, Apo, AP 96278-2060 Ph: (315) 784-0196 | Dr Peter Edward Carra, OD Unit 2060 Box 51st, Apo, AP 96278-2060 Ph: (314) 784-0196 |
News Archive
Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen, today announced that the U.S. Food and Drug Administration (FDA) has approved a new device to deliver Somatuline Depot (lanreotide). The device has an enhanced, prefilled, low-volume syringe that supports full-dose delivery with no reconstitution requirements.
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.
Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.
Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.
About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.
› Verified 2 days ago
Dr. Justin E Sandholm, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 35 Hcos/cc, Psc 76 Unit 5024, Apo, AP 96319 Phone: 071-677-6269 | |
Lewis Bruneel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 18th Medical Group, Apo, AP 96368 Phone: 544-630-2947 | |
Melanie A Riley Peters, OD Optometrist Medicare: Medicare Enrolled Practice Location: 121 Brian Allgood Hospital, Unit 15244, Apo, AP 96205 Phone: 315-737-1470 | |
Timothy Soh, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Brian D. Allgood Army Community Hospital, Dha, Apo, AP 96271 Phone: 315-737-1449 | |
Dr. Nicole Elizabeth Nowling, OD Optometrist Medicare: Medicare Enrolled Practice Location: 51st Medical Group, Unit 2060, Apo, AP 96278 Phone: 315-784-2151 | |
Nicholas Jon Hardgrave, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 36th Medical Group-andersen Afb Clinic/optometry, Unit 14010, Apo, AP 96543 Phone: 671-366-6749 | |
Dr. Min Kyung Kim, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Unit 15245, Apo, AP 96271 Phone: 315-737-1219 |